Josh Resnick’s STAAR Surgical STAA Stock Holding History

Josh Resnick’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-115,982	Closed	-$7.14M	–	58
2020 Q2	$7.14M	Sell	115,982 -94,000	-45%	-$3.84M	0.28%	42
2020 Q1	$6.77M	Hold	209,982	–	–	0.54%	25
2019 Q4	$7.38M	Hold	209,982	–	–	0.4%	25
2019 Q3	$5.41M	Buy	+209,982	New	+$6.38M	0.31%	18

Other funds holding STAA

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EIM

Elephas Investment Management Hong Kong $367M AUM 189.12% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Josh Resnick's STAA Position: Q3 2020 in Review

Josh Resnick sold out of STAAR Surgical (STAA) in Q3 2020, closing a stake of 115,982 shares — an estimated $7.14M sold.

Josh Resnick first reported a position in STAA in Q3 2019 and held it in 4 quarters. The position peaked at $7.38M in Q4 2019. 178 funds tracked by Wall St. Rank hold STAA as of Q3 2020.

Josh Resnick reported no remaining STAAR Surgical position as of Q3 2020 after selling out during the quarter.
Josh Resnick sold 115,982 STAAR Surgical shares in Q3 2020, an estimated $7.14M.
Josh Resnick first reported a position in STAAR Surgical in Q3 2019 and held it in 4 quarters.
Josh Resnick's STAAR Surgical position peaked at $7.38M in Q4 2019.
178 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2020.

Based on Jericho Capital Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.